Precipio price to free cash flow PRPO

Market value divided by free cash flow over the last twelve months, since 2025.

Today, Oct 23, 2026: 45.4×
Peer median: 11.8×

Precipio's price to free cash flow is 45.4× as of Oct 23, 2026.

The median for 10 healthcare stocks of a similar size is 11.8×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	45.4×	45.4×	154×
2025	70.7×	40.9×	74.3×

Against its peers

Companies in Healthcare nearest Precipio's size, closest first, today.

Company	Price to free cash flow
PRPOPrecipio	45.4×
NEPHNephros	n/m
ATNMActinium Pharmaceuticals	n/m
APTAlpha Pro Tech	9.7×
SPROSpero Therapeutics	n/m
LFVNLifevantage	11.0×
ICCCImmucell	22.1×
KEQUKewaunee Scientific	8.7×
PDEXPro DEX	29.5×
PLXProtalix BioTherapeutics	26.8×
NATRNatures Sunshine Products	11.8×
Peer median	11.8×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Precipio

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.